TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrPC

出版年份 2019 全文链接

标题

作者

关键词

Chronic kidney disease, Mesenchymal stem cell, Tauroursodeoxycholic acid, Cellular prion protein, PINK1, Mitochondria, Mitophagy

出版物

Redox Biology

Volume 22, Issue -, Pages 101144

出版商

Elsevier BV

发表日期

2019-02-16

DOI

10.1016/j.redox.2019.101144

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More